Immune checkpoint therapies (ICT) can reinvigorate the effector functions of anti-tumour T
cells, improving cancer patient outcomes. Anti-tumour T cells are initially formed during their …

Simple Summary Vitreoretinal lymphoma is a variant of primary CNS lymphoma involving
the retina and/or the vitreous. At the time of presentation, CNS involvement occurs in up to …

Vitreoretinal lymphoma (VRL) is a rare subtype of diffuse large B-cell lymphoma (DLBCL)
considered a variant of primary central nervous system lymphoma (PCNSL). The diagnosis …

Simple Summary A diagnosis of diffuse large B-cell lymphoma in our therapeutic era should
be implemented by the definition of the cell of origin, additional immunohistochemistry (ie …

Primary vitreoretinal lymphoma (PVRL), a rare aggressive malignancy primarily involving
the retina and/or the vitreous, is a major diagnostic challenge for clinicians (who commonly …

In the twentieth century, a conspicuous lack of effective treatment strategies existed for
managing several retinal disorders, including age-related macular degeneration; diabetic …

Purpose: Vitreoretinal lymphoma (VRL) is a non-Hodgkin lymphoma of the diffuse large B
cell type (DLBCL), which is an aggressive cancer causing central nervous system related …

Primary central nervous system lymphoma (PCNSL) is a rare and aggressive form of extra-
nodal non-Hodgkin lymphoma that as a brain tumor poses a unique set of challenges in …

Vitreoretinal lymphoma (VRL) is a rare ocular malignancy that manifests as diffuse large B-
cell lymphoma. Early and accurate diagnosis is essential to prevent mistreatment and to …

Uveal melanoma (UM) is the most common primary adult intraocular malignancy. This rare
but devastating cancer causes vision loss and confers a poor survival rate due to distant …